| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | Sep 30, 2025 | Norbury Capital | - | 24.4% | AZE.BR, IMCD.AS, MEDCL.PA, PHLL.L | Consolidation, Distribution, Europe, SmallCap, Specialty Chemicals | Focus on high-quality specialty chemicals distribution businesses like Azelis and IMCD that connect suppliers with smaller end-customers. These asset-light businesses benefit from industry consolidation and outsourcing trends, with operational profit closely aligning with free cash flow. However, the sector faces headwinds from prolonged destocking cycles and weak global trade conditions. | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||